For adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD).

Request a Rep

If you’d like to learn more information about ENTYVIO (vedolizumab) for the treatment of moderate to severe ulcerative colitis or Crohn’s disease, fill out the form below to connect with a Clinical Sales Specialist.

Thank you.

An ENTYVIO Clinical Sales Specialist will be in touch soon.